Effect of Percutaneous Balloon Compression on Trigeminal Neuralgia and Clinical Significance of NLRP3 Before and After Treatment

• Published in: Alternative therapies in health and medicine Vol. 30; no. 10; p. 212
• Main Authors: Li, Jun, Wang, Wenhao, Huang, Wei, Lin, Junming, Zheng, Xuefeng, Zhang, Mingsheng, Lin, Zhikun
• Format: Journal Article
• Language: English
• Published: United States 01.10.2024
• Subjects: Adult; Aged; Clinical Relevance; Female; Humans; Male; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Treatment Outcome; Trigeminal Neuralgia - therapy
• ISSN: 1078-6791

Trigeminal neuralgia (TN) is very common in the middle-aged and elderly population and seriously affects the normal life of patients. This study aims to analyze the therapeutic effect of percutaneous balloon compression (PBC) on TN and to explore the clinical significance of NOD-like receptor thermal protein domain associated protein 3 (NLRP3), which not only can provide a reference for the clinical treatment of TN in the future, but also can help the clinic to find a reliable indicator for the assessment of TN condition. The length of stay, total cost of hospitalization, and adverse reactions during treatment were compared between the two groups. Patients were subjected to assessments or investigations of the Barrow Neurological Institute (BNI) scale, Pittsburgh Sleep Quality Index (PSQI), Self-rating Anxiety Scale (SAS), and Self-rating Depression Scale (SDS) before and after treatment. In addition, NLRP3 in the peripheral blood of patients in the research group was measured, and the correlation of NLRP3 with BNI score and prognosis for recurrence was analyzed. The length of stay and the total cost of hospitalization were respectively (12.10±2.20) d and (26445.96±5553.78) yuan in the research group, significantly reduced than those in the control group (P < .05). And the BNI score, PSQI and SAS/SDS were lower in the research group after treatment (P < .05), but the incidence of facial numbness, herpes orofacialis and masticatory muscle weakness were higher in the research group than in the control group (P < .05). After treatment, NLRP3 decreased in the research group, which was positively correlated with BNI score (P < .05). In addition, NLRP3 showed an excellent effect in predicting recurrence. PBC effectively improved the pain and negative psychological status of patients with TN, and NLRP3 was closely related to the pain of patients with TN. In the future, PBC is used in the clinic to treat TN and improve the prognosis of patients.